| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/04/2009 | US7569558 Chromium benfotiamine picolinate, copper adenosine triphosphate gluconate or vanadium pyridoxal-5-phosphate oxoglycinate; modulation of metalloenzymes; antiinflammatory, skin whitening, wrinkle reduction, skin aging control, cellular antioxidant, acne control, hair growth modulation |
| 08/04/2009 | US7569553 Dna bacteria; activate lymphocytes; nucleotide sequences; antigens; administering cytokines |
| 08/04/2009 | US7569551 Administering composition effective to inhibit expression of testosterone-repressed prostate message-2 gene in renal cell cancer |
| 08/04/2009 | US7569232 Medium chain peroxycarboxylic acid compositions |
| 08/04/2009 | CA2566440C An antimycobacterial pharmaceutical composition |
| 08/04/2009 | CA2433785C Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/04/2009 | CA2420348C Non-hormonal vaginal contraceptive |
| 08/04/2009 | CA2392367C Composition and method for treatment of otitis media |
| 08/04/2009 | CA2347447C Buffered compositions for dialysis |
| 08/04/2009 | CA2322745C Method of treating neuroma pain |
| 07/30/2009 | WO2009094473A1 Methods and compositions for topical treatment of medical conditions including wounds and inflammation |
| 07/30/2009 | WO2009093629A1 Prophylactic or therapeutic agent for malaria |
| 07/30/2009 | WO2009093264A2 Pharmaceutical combinations comprising specified age breaker and further drugs, i.a. antihypertensive drugs, antidiabetic drugs etc. |
| 07/30/2009 | WO2009092892A2 Novel composition for treating the side effects of anticancer treatments |
| 07/30/2009 | WO2009092810A2 Single pharmaceutical composition containing antibiotics and probiotics |
| 07/30/2009 | WO2009092442A1 Treatment of portal hypertension and related conditions by combined inhibition of the vegf and pdgf signalling pathways |
| 07/30/2009 | WO2009076170A3 Combinations of therapeutic agents for treating cancer |
| 07/30/2009 | WO2009061786A3 Combination therapy comprising angiotensin converting enzyme inhibitors and vasopressin receptor antagonists |
| 07/30/2009 | WO2009047505A3 Dexanabinol with inhibitors of braf or mek for the treatment of melanoma |
| 07/30/2009 | WO2009037503A3 New combination - 012 for the treatment of respiratory diseases |
| 07/30/2009 | WO2009027349A3 Treatment and prevention of neurodegenerative diseases |
| 07/30/2009 | WO2008157302A3 Methods for treatment and prevention of tauopathies and amyloid beta amyloidosis by modulating crf receptor signaling |
| 07/30/2009 | WO2008127975A3 Use of an inhibitor of tnfa plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis |
| 07/30/2009 | WO2008100449A4 Therapeutic effects of bryostatins, bryologs, and other related substances on head trauma-induced memory impairment and brain injury |
| 07/30/2009 | US20090192293 Antibodies to non-functional p2x7 receptor |
| 07/30/2009 | US20090192211 Cyclooxygenase-2 inhibitor/histone deacetylase inhibitor combination |
| 07/30/2009 | US20090192177 2-ARYL pyrrologpyrimidines for A1 and A3 receptors |
| 07/30/2009 | US20090192137 Dialysis method |
| 07/30/2009 | US20090192123 Optionally in combination with antithrombotic agents, ACE inhibitor, Angiotensin antagonist, Calcium antagonist, statins, or antidiabetic agents |
| 07/30/2009 | US20090192109 Compositions for diagnosis and therapy of diseases associated with aberrant expression of Kremen and/or Wnt |
| 07/30/2009 | US20090192089 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 07/30/2009 | US20090191640 Methods of Screening for Atherosclerosis |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191570 Inhibition of Interaction of PSD93 and PSD95 with nNOS and NMDA Receptors |
| 07/30/2009 | US20090191282 Controlled release composition containing a strontium salt |
| 07/30/2009 | US20090191237 Methods and reagents for vaccination which generate A CD8 T cell immune response |
| 07/30/2009 | US20090191215 Treatment with anti-VEGF Antibodies |
| 07/30/2009 | US20090191207 Compositions and methods for the prophylaxis or treatment of viral diseases |
| 07/30/2009 | US20090191188 Immunostimulatory nucleic acids |
| 07/30/2009 | US20090191173 Induction Of Neurogenesis And Stem Cell Therapy In Combination With Copolymer 1 |
| 07/30/2009 | US20090191163 Primed tissue for tissue engineering and methods of priming tissue |
| 07/30/2009 | US20090191159 Multipotent/pluripotent cells and methods |
| 07/30/2009 | US20090191149 IL-1alpha IMMUNIZATION INDUCES AUTOANTIBODIES PROTECTIVE AGAINST ATHEROSCLEROSIS |
| 07/30/2009 | US20090191146 Methods for the modulation of neovascularization and/or the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/30/2009 | US20090188491 Medicaments |
| 07/29/2009 | EP2083368A1 Database and method for creating a database for classifying and treating physiologic brain imbalances using quantitative eeg |
| 07/29/2009 | EP2083272A1 Cancer cell identification marker and cancer cell proliferation inhibitor |
| 07/29/2009 | EP2083267A1 Diagnosis and treatment of autism using cd38 |
| 07/29/2009 | EP2082754A1 Bone defect filler, release-controlled carrier, and their production methods |
| 07/29/2009 | EP2082749A2 Prevention and treatment of Alzheimer's disease |
| 07/29/2009 | EP2082731A1 Use of a combination of hesperidin and a micro-organism to act on the barrier function of the skin |
| 07/29/2009 | EP2081648A2 Carbamate compounds for use in treating depression |
| 07/29/2009 | EP2081600A1 Combination of nmda- receptor ligand and a compound with 5-ht6 receptor affinity |
| 07/29/2009 | EP2081599A2 Compounds, kits and methods for conferring cytoprotection |
| 07/29/2009 | EP2081598A2 Bioavailable combinations for hcv treatment |
| 07/29/2009 | EP2081597A1 Long-term enteral feed for maintenance |
| 07/29/2009 | EP2081568A1 Compositions containing zinc salts for coating medical articles |
| 07/29/2009 | EP2081561A2 Methods and compositions using immunomodulatory compounds for the treatment and management of spirochete and other obligate intracellular bacterial diseases |
| 07/29/2009 | EP2081431A1 Organic compounds |
| 07/29/2009 | EP1628667B1 Method for treating diseases using hsp90-inhibiting agents in combination with antimitotics |
| 07/29/2009 | EP1406608B1 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 07/29/2009 | EP1399221B1 Compositions comprising oestrone-3-o-sulphamate and trail (tnf-related apoptosis inducing ligand) |
| 07/29/2009 | EP1363876B1 Glucocorticoid receptor modulators |
| 07/29/2009 | EP1347805B1 Pharmaceutical preparation for douches and/or irrigations of natural or pathological cavities in the human body |
| 07/29/2009 | EP1292676B1 Mutation associated with epilepsy |
| 07/29/2009 | EP1189641B1 HUMANIZED ANTI-ErbB2 ANTIBODIES AND TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 07/29/2009 | CN101495148A Pharmaceutical composition comprising at least one anticancer drug and at least one polymer |
| 07/29/2009 | CN101495147A Pharmaceutical combinations. |
| 07/29/2009 | CN101495146A Muscle regeneration promoter |
| 07/29/2009 | CN101491675A Composite lipid-regulation medicine |
| 07/29/2009 | CN101491670A Method for treating cardiovascular disease using nervous regulation protein and composite |
| 07/29/2009 | CN101491536A Therapeutically useful synthetic oligonucleotides |
| 07/29/2009 | CN100520408C Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 07/29/2009 | CN100519527C Inhibitors of histone deacetylase |
| 07/29/2009 | CN100519525C Aromatic sulfones and their medical use |
| 07/29/2009 | CN100518828C Prolonged release biodegradable microspheres and method for preparing same |
| 07/29/2009 | CN100518825C Compound preparation for anti-pregnancy by killing sperm and sterilizing, preparation method thereof |
| 07/29/2009 | CN100518820C A Pharmaceutical formulation containing an inhibitor of carboxypeptidase U and a thrombin inhibitor |
| 07/29/2009 | CN100518816C Application of neurotoxin therapy for the treatment of urinary system disease or related diseases |
| 07/29/2009 | CN100518741C Pregnane steroids for use in the treatment of cns dysfunction |
| 07/29/2009 | CN100518739C A retroviral immunotherapy |
| 07/29/2009 | CN100518733C Compositions for the treatment and prevention of diabetes mellitus |
| 07/28/2009 | US7566740 Method of treating mucositis |
| 07/28/2009 | US7566705 Combination of formoterol and mometasone furoate for asthma |
| 07/28/2009 | US7566566 Materials and methods involving hybrid vascular endothelial growth factor DNAs and proteins |
| 07/28/2009 | US7566550 Screening method for developing drugs against pathogenic microbes having two-component system |
| 07/28/2009 | US7566449 Method and composition for inhibition of angiogenesis using antagonists based on MMP-9 and β1 integrins |
| 07/28/2009 | US7566446 Wound healing and treatment of fibrosis |
| 07/28/2009 | US7566445 Canister comprising container closed with metering valve, comprising pharmaceutical suspension aerosol formulation free of surfactant, which consists of salbutamol sulphate, ethanol, and 1,1,1,2-tetrafluoroethane; higher levels of ethanol have beneficial results |
| 07/28/2009 | CA2472008C Combined therapy against tumors comprising substituted acryloyl distamycin derivatives and protein kinase (serine/threonine kinase) inhibitors |
| 07/28/2009 | CA2443012C Use of pyridoindolone derivatives for preparing medicines |
| 07/28/2009 | CA2387787C Nutritional composition for treating inflammatory bowel diseases |
| 07/28/2009 | CA2316447C Rantes mutants and therapeutic applications thereof |
| 07/28/2009 | CA2304899C New use of selective serotonin reuptake inhibitors for treatment of human patients with chest pain of non-cardiac origin or with gastro-esophageal reflux disease |
| 07/23/2009 | WO2009091889A1 Treatment of skin disorders with egfr inhibitors |
| 07/23/2009 | WO2009091082A1 Combination therapy comprising sglt inhibitors and dpp4 inhibitors |
| 07/23/2009 | WO2009091059A1 Composition for diagnosis, treatment or prevention of epilepsy |
| 07/23/2009 | WO2009090656A2 Combination therapy of beta-glycolipids and antibodies for the treatment of immune-related disorders |
| 07/23/2009 | WO2009090648A2 Use of antimicrobial polymers for re-sensitization of microorganisms upon emergence of resistance to anti-microbial agents |